期刊的影响因子--文章列表

期刊文章列表
Xiangshi Sun¹，Xiaoxuan Xu²，Jue Wang²，Xinyue Zhang³，Zitong Zhao²，Xiaochen Liu²，Guanru Wang²，Lesheng Teng⁴，Xia Chen¹，Dangge Wang^2,5，Yaping Li^2,6,3（Department of Pharmacology，College of Basic Medical Sciences，Jilin University；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Life Sciences，Jilin University；Yantai Key Laboratory of Nanomedicine & Advanced Preparations，Yantai Institute of Materia Medica；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery）.Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells[J].Acta Pharmaceutica Sinica B,2023,第7期 Yi Zhou^1,2，Yingling Miao²，Qiudi Huang²，Wenwen Shi²，Jiacui Xie^2,3，Jiachang Lin²，Pei Huang^2,3，Chengfeng Yue^2,4，Yuan Qin²，Xiyong Yu²，He Wang⁴，Linghao Qin³，Jianhai Chen¹（Nanfang Hospital，Southern Medical University；Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease and the Fifth Affiliated Hospital，School of Pharmaceutical Sciences，Guangzhou Medical University；School of Pharmacy，Guangdong Pharmaceutical University；Center of Cancer Research，The Second Affiliated Hospital，Guangzhou Medical University）.A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression[J].Acta Pharmaceutica Sinica B,2023,第7期 Yanqiong Zhang¹，Xin Li¹，Yulong Shi²，Tong Chen³，Zhijian Xu²，Ping Wang¹，Meng Yu¹，Wenjia Chen¹，Bing Li¹，Zhiwei Jing⁴，Hong Jiang¹，Lu Fu¹，Wenjing Gao¹，Yanhua Jiang⁴，Xia Du⁵，Zipeng Gong⁶，Weiliang Zhu²，Hongjun Yang⁷，Haiyu Xu¹（Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；State Key Laboratory of Drug Research，Drug Discovery and Design Center，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；National Resource Center for Chinese Materia Medica，Chinese Academy of Chinese Medical Sciences；Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences；Shaanxi Academy of Traditional Chinese Medicine；State Key Laboratory of Functions and Applications of Medicinal Plants，Guizhou Provincial Key Laboratory of Pharmaceutics，Guizhou Medical University；China Academy of Chinese Medical Sciences）.ETCM v2.0：An update with comprehensive resource and rich annotations for traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2023,第6期 Lingling Zhu¹，Xianzhe Yu，Ting Cao³，Hanyu Deng¹，Xiaojun Tang¹，Qing Lin¹，Qinghua Zhou¹（Lung Cancer Center/Lung Cancer Institute，West China Hospital & West China School of Pharmacy，Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan University；Department of Gastrointestinal Surgery，Chengdu Second People’s Hospital；Laboratory of Infectious Diseases and Vaccine，West China Hospital，Sichuan University）.Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis[J].Acta Pharmaceutica Sinica B,2023,第6期 Bingbing Li¹，Chao Teng²，Huiling Yu^1,3，Xiaohong Jiang²，Xuyang Xing²，Qi Jiang²，Chenshi Lin²，Zongmin Zhao⁴，Ruifeng Zhang⁵，Wei He^2,6（Department of Anesthesiology，Affiliated Drum Tower of Nanjing University；School of Pharmacy，China Pharmaceutical University；Department of Anesthesiology，Women's Hospital of Nanjing Medical University，Nanjing Maternity and Child Health Care Hospital；Department of Pharmaceutical Sciences，College of Pharmacy，University of Illinois at Chicago；Department of Respiratory Medicine，Zhongda Hospital of Southeast University；Shanghai Skin Disease Hospital，Tongji University School of Medicine）.Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries[J].Acta Pharmaceutica Sinica B,2023,第6期 Yanlin Luo^1,2,3，Yibing Chen⁴，Huan Jin²，Benxin Hou，Hongsheng Li⁶，Xiang Li⁷，Lingfeng Liu²，Yuan Zhou²，Yonghua Li²，Yong Sang Song⁸，Quentin Liu⁹，Zhengzhi Zou^2,10（Department of Gynecologic Oncology，the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital；MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science，Guangdong Provincial Key Laboratory of Laser Life Science，College of Biophotonics，South China Normal University；Institute of Clinical Pharmacology，School of Basic Medical Science，Academy of Medical Science，Zhengzhou University；Genetic and Prenatal Diagnosis Center，Department of Gynecology and Obstetrics，First Affiliated Hospital，Zhengzhou University；Department of General Surgery，the Third People’s Hospital of Hainan Province；Department of Breast Surgery，Affiliated Cancer Hospital & Institute of Guangzhou Medical University；Department of Pathophysiology，School of Basic Medical Sciences，Zhengzhou University；Department of Obstetrics and Gynecology，Cancer Research Institute，College of Medicine，Seoul National University；State Key Laboratory of Oncology in South China，Cancer Center，Sun Yat-sen University；Guangzhou Key Laboratory of Spectral Analysis and Functional Probes，College of Biophotonics，South China Normal University）.The suppression of cervical cancer ferroptosis by macrophages：The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes[J].Acta Pharmaceutica Sinica B,2023,第6期 Xin Jin^1,2,3，Tingting Qiu¹，Li Li¹，Rilei Yu¹，Xiguang Chen²，Changgui Li⁴，Christopher G.Proud⁵，Tao Jiang¹（School of Medicine and Pharmacy，Ocean University of China and Laboratory for Marine Drugs and Bioproducts，Qingdao National Laboratory for Marine Science and Technology；College of Marine Life Sciences，Ocean University of China；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery；Shandong Provincial Key Laboratory of Metabolic Diseases，Qingdao Key Laboratory of Gout，Affiliated Hospital of Qingdao University Medical College，Qingdao University；Lifelong Health Theme，South Australian Health and Medical Research Institute）.Pathophysiology of obesity and its associated diseases[J].Acta Pharmaceutica Sinica B,2023,第6期 Jiayi Luan¹，Ruotao Li²，Weiguo Xu³，Huiying Sun¹，Qiqi Li¹，Di Wang¹，Shujun Dong¹，Jianxun Ding³（VIP Integrated Department，Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling，School and Hospital of Stomatology，Jilin University；Department of Hand and Foot Surgery，the First Hospital of Jilin University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences）.Functional biomaterials for comprehensive periodontitis therapy[J].Acta Pharmaceutica Sinica B,2023,第6期 Jianxun Zhu¹，Tianyue An²，Wenlong Zha¹，Ke Gao²，Ting Li²，Jiachen Zi¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs，and NHC Key Laboratory of Biosynthesis of Natural Products，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College；College of Pharmacy，Jinan University）.Manipulation of IME4 expression, a global regulation strategy for metabolic engineering in Saccharomyces cerevisiae[J].Acta Pharmaceutica Sinica B,2023,第6期 Weirong Kang^1,2,3，Yuwei Liu^1,2,3，Weiping Wang^1,2,3（State Key Laboratory of Pharmaceutical Biotechnology，the University of Hong Kong；Department of Pharmacology and Pharmacy，Li Ka Shing Faculty of Medicine，the University of Hong Kong；Laboratory of Molecular Engineering and Nanomedicine，Dr.Li Dak-Sum Research Centre，the University of Hong Kong）.Light-responsive nanomedicine for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第6期 Yanping Wang^1,2，Yanfeng Gao¹，Yongchun Pan¹，Dongtao Zhou¹，Yuta Liu¹，Yi Yin¹，Jingjing Yang¹，Yuzhen Wang³，Yujun Song¹（College of Engineering and Applied Sciences，State Key Laboratory of Analytical Chemistry for Life Science，Nanjing University；Sino-French Engineer School，Nanjing University of Science and Technology；Key Laboratory of Flexible Electronics & Institute of Advanced Materials，Jiangsu National Synergistic Innovation Center for Advanced Materials，Nanjing Tech University）.Emerging trends in organ-on-a-chip systems for drug screening[J].Acta Pharmaceutica Sinica B,2023,第6期 Chen Shi^1,2，Cong Zhang¹，Zhiwen Fu¹，Jinmei Liu¹，Yuanfeng Zhou³，Bao Cheng⁴，Cong Wang¹，Shijun Li¹，Yu Zhang^1,2（Department of Pharmacy，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Hubei Province Clinical Research Center for Precision Medicine for Critical Illness；Department of Preclinical Translational Science，Shanghai Hansoh Biomedical Co.，Ltd.；Department of Chemistry，Shanghai Hansoh Biomedical Co.，Ltd.）.Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations[J].Acta Pharmaceutica Sinica B,2023,第6期 Pengyun Li^1,2，Changkai Jia^1,2，Zhiya Fan³，Xiaotong Hu¹，Wenjuan Zhang¹，Ke Liu²，Shiyang Sun¹，Haoxin Guo⁴，Ning Yang¹，Maoxiang Zhu⁴，Xiaomei Zhuang²，Junhai Xiao^1,2，Zhibing Zheng^1,2，Song Li^1,2（National Engineering Research Center for Strategic Drugs，Beijing Institute of Pharmacology and Toxicology Institution；State Key Laboratory of Toxicology and Medical Countermeasures，Beijing Institute of Pharmacology and Toxicology；National Center for Protein Sciences(Beijing)，Beijing Institute of Lifeomics，State Key Laboratory of Proteomics，Beijing Proteome Research Center；Beijing Key Laboratory for Radiobiology，Beijing Institute of Radiation Medicine）.Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations[J].Acta Pharmaceutica Sinica B,2023,第6期 Jing Chen¹，Peng Ji¹，Giri Gnawali¹，Mengyang Chang²，Feng Gao¹，Hang Xu¹，Wei Wang^1,2,3（Department of Pharmacology and Toxicology，University of Arizona；Department of Chemistry and Biochemistry，University of Arizona；BIO5 Institute，and University of Arizona Cancer Center，University of Arizona）.Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery[J].Acta Pharmaceutica Sinica B,2023,第6期 Jianping Ye（Metabolic Disease Research Center，Zhengzhou University Affiliated Zhengzhou Central Hospital；Center for Advanced Medicine，College of Medicine，Zhengzhou University；Research Center of Basic Medicine，Academy of Medical Sciences，Zhengzhou University）.Commentary：Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes[J].Acta Pharmaceutica Sinica B,2023,第6期 Qi Zhu¹，Juxian Song^2,3，Jia-Yue Chen¹，Zhenwei Yuan³，Liangfeng Liu^3,5,6，Li-Ming Xie¹，Qiwen Liao⁷，Richard D.Ye⁷，Xiu Chen¹，Yepiao Yan¹，Jieqiong Tan⁸，Chris Soon Heng Tan⁹，Min Li³，Jia-Hong Lu¹（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Medical College of Acupuncture-Moxibustion and Rehabilitation，Guangzhou University of Chinese Medicine；Mr. and Mrs. Ko Chi Ming Centre for Parkinson's Disease Research，School of Chinese Medicine，Hong Kong Baptist University；Mr. and Mrs. Ko Chi Ming Centre for Parkinson’s Disease Research，School of Chinese Medicine，Hong Kong Baptist University；Guangdong Corporate Key Laboratory of High-end Liquid Medicine R&D，Industrialization；Limin Pharmaceutical Factory，Livzon Pharmaceutical Group Inc.；Kobilka Institute of Innovative Drug Discovery，School of Medicine，the Chinese University of Hong Kong；Center for Medical Genetics，Life Science School，Central South University；Department of Chemistry，College of Science，Southern University of Science and Technology）.Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinson’s disease[J].Acta Pharmaceutica Sinica B,2023,第6期 Yuehong Ren¹，Wei Wu^2,3，Xingwang Zhang¹（Department of Pharmaceutics，College of Pharmacy，Jinan University；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University）.The feasibility of oral targeted drug delivery：Gut immune to particulates?[J].Acta Pharmaceutica Sinica B,2023,第6期 Kezheng Peng¹，Chenye Zeng¹，Yuqi Gao¹，Binliang Liu²，Liyuan Li¹，Kang Xu¹，Yuemiao Yin¹，Ying Qiu³，Mingkui Zhang⁴，Fei Ma²，Zhao Wang¹（The Ministry of Education Key Laboratory of Protein Science，School of Pharmaceutical Sciences，Tsinghua University；Department of Medical Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；School of Medicine，Tsinghua University；Department of Cardiac Surgery，First Hospital of Tsinghua University）.Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling[J].Acta Pharmaceutica Sinica B,2023,第6期 Xiaomin Wang^1,2，Jun Xu^1,2，Yiming Sun¹，Siyuwei Cao¹，Hanlin Zeng¹，Nan Jin¹，Matthew Shou³，Shuai Tang¹，Yi Chen^1,2，Min Huang^1,2,4（Cancer Research Center，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Division of Diabetes，Endocrinology and Metabolism，Department of Molecular Physiology and Biophysics，Vanderbilt University Medical Center；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences）.Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer[J].Acta Pharmaceutica Sinica B,2023,第6期 Chao Chen¹，Wu Zhong²，Shiyu Du¹，Yayao Li¹，Yunfei Zeng²，Kunguo Liu¹，Jingjing Yang¹，Xiaoxiang Guan³，Xin Han¹（Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization，School of Medicine & Holistic Integrative Medicine，Nanjing University of Chinese Medicine；Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province，School of Medicine，Hunan Normal University；Department of Oncology，the First Affiliated Hospital of Nanjing Medical University）.Intelligent nanotherapeutic strategies for the delivery of CRISPR system[J].Acta Pharmaceutica Sinica B,2023,第6期 Jiahui He¹，Yuyue Zhang¹，Xinge Yu^1,2，Chenjie Xu¹（Department of Biomedical Engineering，City University of Hong Kong；Hong Kong Centre for Cerebro-Cardiovascular Health Engineering）.Wearable patches for transdermal drug delivery[J].Acta Pharmaceutica Sinica B,2023,第6期 Tao Liang^1,2，Fengli Wang³，Reham M.Elhassan²，Yongmei Cheng¹，Xiaolei Tang^3,4，Wengang Chen¹，Hao Fang²，Xuben Hou²（Department of Pharmacy，the Second Hospital Affiliated Wannan Medical College；Department of Medicinal Chemistry and Key Laboratory of Chemical Biology(Ministry of Education)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University；Department of Science and Education，Translational Medicine Center & Vascular Disease Research Center，the Second Hospital Affiliated Wannan Medical College；Clinical Pathogens Detection Engineering Center of Wuhu）.Targeting histone deacetylases for cancer therapy：Trends and challenges[J].Acta Pharmaceutica Sinica B,2023,第6期 Shenghua Gao^1,2,3，Letian Song¹，Yusen Cheng¹，Fabao Zhao¹，Dongwei Kang^1,2，Shu Song¹，Mianling Yang¹，Bing Ye¹，Wei Zhao⁴，Yajie Tang⁴，Erik De Clercq⁵，Christophe Pannecouque⁵，Peng Zhan^1,2，Xinyong Liu^1,2（Department of Medicinal Chemistry，Key Laboratory of Chemical Biology，Ministry of Education，School of Pharmaceutical Sciences，Shandong University；China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province；Shenzhen Research Institute of Shandong University，A301 Virtual University Park in South District of Shenzhen；State Key Laboratory of Microbial Technology，Shandong University；Rega Institute for Medical Research，K.U.Leuven）.Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles[J].Acta Pharmaceutica Sinica B,2023,第6期 Gaona Shi¹，Yu Zhou¹，Wenshuai Liu²，Chengjuan Chen¹，Yazi Wei¹，Xinlong Yan³，Lei Wu¹，Weiwei Wang²，Lan Sun¹，Tiantai Zhang¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；Tianjin Key Laboratory of Biomaterial Research，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College；Faculty of Environmental and Life Sciences，Beijing University of Technology）.Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A_2A/2B receptors in tolerogenic dendritic cells[J].Acta Pharmaceutica Sinica B,2023,第6期 Guangsheng Du，Ming Qin，Xun Sun（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Recent progress in application of nanovaccines for enhancing mucosal immune responses[J].Acta Pharmaceutica Sinica B,2023,第6期 Qian Yu^1,2，Chang Li^2,3，Qinghui Niu⁴，Jigang Wang⁵，Zhaodi Che⁶，Ke Lei¹，He Ren¹，Boyi Ma¹，Yixing Ren⁷，Pingping Luo⁶，Zhuming Fan²，Huan Zhang^8,9，Zhaohui Liu³，George L.Tipoe²，Jia Xiao^6,7（Tumor Immunology and Cytotherapy of Medical Research Center，and Center for GI Cancer Diagnosis and Treatment，the Affiliated Hospital of Qingdao University；Bau Institute of Medical and Health Sciences Education and School of Biomedical Sciences，LKS Faculty of Medicine，the University of Hong Kong；School of Biomedical Sciences，the Chinese University of Hong Kong；Department of Liver Center，the Affiliated Hospital of Qingdao University；Department of Pathology，the Affiliated Hospital of Qingdao University；Clinical Medicine Research Institute and Department of Metabolic and Bariatric Surgery，the First Affiliated Hospital of Jinan University；Department of General Surgery，and Institute of Hepato-Biliary-Pancreas and Intestinal Disease，Affiliated Hospital of North Sichuan Medical College；Department of Applied Biology and Chemical Technology，the Hong Kong Polytechnic University；Research Center for Chinese Medicine Innovation，the Hong Kong Polytechnic University）.Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis[J].Acta Pharmaceutica Sinica B,2023,第6期首页上一页 4 5 6 7 8 下一页尾页共有12页，转到页

期刊文章列表